Digital | Exploring pharma's evolving digital future

Digital

pharmaphorum podcast Episode 233, Patrick Leung, Faro Health

AI for the planet, AI for life sciences – with Patrick Leung

Patrick Leung – chief technology officer at Faro Health – discusses how AI can transform clinical trials.

Digital

Cracking the code: How European biotechs can win in the US m...

At Frontiers Health 2025, Mike Ryan, General Manager Europe at EVERSANA, tackled one of the most pressing questions for emerging pharma and biotech...

Digital

Stethoscope and UK flag with NHS on wooden blocks spelled out on top

Six ways the NHS can become the UK’s greatest testbed for te...

There are six priorities that would turn the NHS into the UK’s flagship testbed for innovation.

Digital

pharmaphorum podcast Episode 232, Kate Eversole, Celine Parmentier, Emma Slade

On the future of AI in life sciences, with women at the helm

Dive into a conversation on women in AI, with: Kate Eversole, Pharma Brands; Celine Parmentier, Real Chemistry; and Emma Slade, Tangram Therapeutics.

Digital

pharmaphorum podcast Episode 231, Dr Alan Roth, Oxford Drug Design

On AI and computational support of biochemistry, with Alan R...

Dr Alan Roth, CEO of Oxford Drug Design, discusses the use of AI to accelerate discovery of new treatments.

Digital

Key themes from JP Morgan

pharmaphorum editor-in-chief Jonah Comstock is back from San Francisco, where he attended the annual JP Morgan Healthcare Conference.

News

FDA clears AI skin cancer detection device from DermaSensor

Medtech company DermaSensor has claimed FDA approval for a handheld device, powered by artificial intelligence (AI), that can be used to detect skin cancer at the point of

News

Professor Bola Owolabi, director of the National Healthcare Inequalities Improvement Programme at NHS England

Winners named in NHS healthcare inequality contest

A competition aimed at tackling unequal access to healthcare in the NHS has been won by C2-Ai, a company that has developed an artificial intelligence-based risk assessmen

Debates

Spotlight on

Frontiers Health 2025

News

Chai raises $130m for AI drug discovery platform

AI specialist Chai Discovery has said it is sitting on a valuation of around $1.3 billion, after raising $130 million in a Series B financing.

News

Raymond Chua of Singapore's Health Sciences Authority and Lawrence Tallon of the UK Medicines and Healthcare products Regulatory Agency.

UK teams up with Singapore on healthtech regulation

A partnership between medicines regulators in the UK and Singapore could allow patients in both countries to access new medical advances more quickly.

Press Releases

Digital

Partner Content

The PM Society Careers Event – 18th February 2026

Join us for our popular event to see how your skills and interests could add value to this vital and constantly evolving industry.

Digital

Partner Content

Frontiers Health Turns 10

Celebrating a Decade of Innovation and Collaboration in Berlin, November 11–12, 2025 Berlin / November 7th, 2025 | Marking its 10th anniversary,

Views & Analysis

Digital

AI for the planet, AI for life sciences – with Patrick Leung

Patrick Leung – chief technology officer at Faro Health – discusses how AI can transform clinical trials.

Digital

Cracking the code: How European biotechs can win in the US m...

At Frontiers Health 2025, Mike Ryan, General Manager Europe at EVERSANA, tackled one of the most pressing questions for emerging pharma and biotech...

Digital

Six ways the NHS can become the UK’s greatest testbed for te...

There are six priorities that would turn the NHS into the UK’s flagship testbed for innovation.

Deep Dive

Digital

Spatialomics and AI: A new age for personalised clinical med...

Digital

Reimagining the role of medical science liaisons in the age ...

Digital

The practical path to AI: Boosting field productivity in bio...

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Sponsored

Tracking studies get smarter: AI meets human intelligence

Having a continuous pulse on brand health is essential for pharmaceutical companies to inform strategic decisions and establish Key Performance Indicators (KPIs) in an ever-changing market

Digital

Linear visual illustration of nodes in an arrow shape

Sponsored

Enabling Digitally Enhanced Care for Rare Diseases in Europe

Integrating AI and Connected Care Technologies in Lysosomal Storage Disease Patient Journeys

Digital

Sponsored

The AI effect in pharma commercial strategy: From data to re...

Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.

Podcasts

Digital

AI for the planet, AI for life sciences – with Patrick Leung

Patrick Leung – chief technology officer at Faro Health – discusses how AI can transform clinical trials.

Digital

On the future of AI in life sciences, with women at the helm

Dive into a conversation on women in AI, with: Kate Eversole, Pharma Brands; Celine Parmentier, Real Chemistry; and Emma Slade, Tangram Therapeutics.

Digital

On AI and computational support of biochemistry, with Alan R...

Dr Alan Roth, CEO of Oxford Drug Design, discusses the use of AI to accelerate discovery of new treatments.

Video

Digital

Cracking the code: How European biotechs can win in the US m...

At Frontiers Health 2025, Mike Ryan, General Manager Europe at EVERSANA, tackled one of the most pressing questions for emerging pharma and biotech...

Digital

Balancing global consistency and local nuance: EVERSANA on A...

The conversation around global brand launches is evolving rapidly – and EVERSANA and its agency team at EVERSANA INTOUCH’s leadership is at the centre

Digital

Consolidating Digital Health: Insights from Frontiers Health...

Rob Milnes (Ultrahuman) connected with pharmaphorum off the Frontiers Health stage to share some insights.

White Papers

Digital

White paper from Veeva on Clinical Data Industry Research

Sponsored

Data managers and CRAs warn of rising data quality risks due...

A new industry report uncovers the scope of a long-ignored problem in clinical trial operations.

Digital

Sponsored

Future proofing production: Implementing AI in pharmaceutica...

Read Zühlke’s new white paper, ‘Future Proof Production: Implementing AI in pharmaceutical manufacturing’ today.

Digital

Sponsored

The changing landscape of journal performance measurement

In a new white paper from Altmetric – ‘The changing landscape of journal performance measurement’ – learn how publication planners and medical affairs communications teams can leverage the

Event

Spotlight on

Frontiers Health 2025

Digital

Partner Content

The PM Society launches the 40th PM Awards

The PM Awards 2026 competition is launching on 25th September 2025.

Digital

Partner Content

2nd Translational Digital Pathology & AI Summit

Don’t miss the return of this event, uniting 60+ leading biopharma pioneers driving the adoption and utilization of digital pathology

Digital

Sponsored

Digital natives: are pharma companies ready?

Health and life sciences companies face the challenging task of engaging key stakeholders

Views & Analysis

It’s time to tackle the gender health gap with technology

The potential for technology to transform the way we deliver healthcare is nothing new.

Webinars

Debiopharm-Webinar-Image-1200x675-Text-NEW2

Sponsored

The Digital Health Start-up Journey: Series A to scale-up

Although resources exist for digital health entrepreneurs looking to raise their first key investment round, industry advice on next steps is harder to find.